Moderna Inc (MRNA.O) is testing potential vaccines against monkeypox in pre-clinical trials as the disease spreads in the United States and Europe.
The World Health Organization said on Tuesday there have been 131 confirmed monkeypox cases and 106 further suspected cases since the first was reported on May 7 outside the countries where it usually spreads.
Moderna did not immediately respond to a request for more details on the monkeypox vaccines.
The U.S. Centers for Disease Control and Prevention said the government was in the process of releasing doses of a smallpox vaccine Jynneos, made by Bavarian Nordic A/S (BAVA.CO), for use in monkeypox cases.
Reporting by Leroy Leo in Bengaluru; Editing by Shounak Dasgupta
Saudi employer flies to Bangladesh, attends employee's wedding
QU Makes New Achievement in QS Rankings 2023
Qatar Participates in Arab Meeting to Evaluate and Update Media Action Plan Abroad
UK crowns Charles III king at first coronation in 70 years
Leave a comment